New Nature Journals to Launch

Nature Publishing Group announces a slew of online-only, open-access journals.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

One of the new journals is dedicated to the study of biofilms (such as the one pictured above) and micribiomes. WIKIMEDIA, CDCNature Publishing Group today (April 2) announced that it is launching a portfolio of online-only, open-access journals in partnership with institutions, foundations, and academic societies. Called Nature Partner Journals (NPJ), these subject-specific publications are meant to serve “high-impact and emerging or under-served fields,” according to Nature.

One new title, NPJ Schizophrenia, to be run in collaboration with the Schizophrenia International Research Society, will cover research advances related to the disease. NPJ Biofilms and Microbiomes, created in partnership with Nanyang Technological University (NTU) and the Singapore Centre on Environmental Life Sciences Engineering, will “bring together scientists studying the social behavior of complex microbial communities across a wide disciplinary spectrum and covering natural, medical and industrial settings,” NTU President Bertil Andersson said in a statement.

In the announcement, Philip Campbell, editor-in-chief of the publisher’s flagship journal, Nature, said that “research is ever changing, and the Nature Partner Journals are one way in which we can meet the evolving needs of the research community.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies